Current guidance
13 items
Each item compared with the same item in the previous release (Apr 30, 2026). Values in quotation marks are the company’s words.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| New | Net Sales (YoY % growth) | for Q3 FY2026 | — | “LSD%” | Filing ↗ |
| New | Adjusted Diluted EPS | for Q3 FY2026 | — | “~$0.70” | Filing ↗ |
| New | Adjusted EBITDA | for Q3 FY2026 | — | “$295 - $305” | Filing ↗ |
| Reiterated | Adjusted Diluted EPS | for FY2026 | “$2.55 - $2.70” | “$2.55 - $2.70” | Filing ↗ |
| Reiterated | Adjusted EBITDA | for FY2026 | “$1,140 - $1,170” | “$1,140 - $1,170” | Filing ↗ |
| Reiterated | Capital Expenditures | for FY2026 | “$180 - $200” | “$180 - $200” | Filing ↗ |
| Reiterated | Depreciation and Amortization | for FY2026 | “$305” | “$305” | Filing ↗ |
| Reiterated | Diluted Shares Outstanding | for FY2026 | “~215” | “~215” | Filing ↗ |
| Reiterated | Free Cash Flow | for FY2026 | “>$500” | “>$500” | Filing ↗ |
| Reiterated | Tax Rate, As Adjusted | for FY2026 | “~24%” | “~24%” | Filing ↗ |
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Net Sales (YoY % growth) | “LSD%” | for Q3 FY2026 | GAAP-tied | Jul 28, 2026 | 1 | Filing ↗ |
| Net Sales (YoY % growth) | “LSD%” | for FY2026 | GAAP-tied | Apr 30, 2026 | 1 | Filing ↗ |
| Net Sales (YoY% growth) | “LSD%” | for FY2026 | GAAP-tied | Feb 10, 2026 | 1 | Filing ↗ |
| Adjusted Diluted EPS | “~$0.70” | for Q3 FY2026 | Company-defined | Jul 28, 2026 | 1 | Filing ↗ |
| Adjusted Diluted EPS | “$2.55 - $2.70” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Adjusted EBITDA | “$295 - $305” | for Q3 FY2026 | Company-defined | Jul 28, 2026 | 1 | Filing ↗ |
| Adjusted EBITDA | “$1,140 - $1,170” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Capital Expenditures | “$180 - $200” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Depreciation and Amortization | “$305” | for FY2026 | GAAP-tied | Feb 10, 2026 | 3 | Filing ↗ |
| Diluted Shares Outstanding | “~215” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Free Cash Flow | “>$500” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Interest Expense | “$150 - $160” | for FY2026 | GAAP-tied | Feb 10, 2026 | 1 | Filing ↗ |
| Tax Rate, As Adjusted | “~24%” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
Net Sales, for FY2025 — every statement across the year, each linked to its filing.
12 companies in Specialty chemicals. What they guide on, and who reported this season.
| RPM International | Oct 6, 2026 | 5 changes |
| Albemarle | Aug 5, 2026 | 24 changes |
| DuPont | Aug 4, 2026 | 11 changes |
| Cabot Corporation | Aug 3, 2026 | 4 changes |
| Eastman Chemical | Jul 30, 2026 | 9 changes |
| Huntsman | Jul 30, 2026 | 1 change |
| FMC Corporation | Jul 29, 2026 | 34 changes |
| Ashland | Jul 28, 2026 | 4 changes |
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Net Sales (YoY % growth) | 4 statements | 8 statements | 1 statement |
| Adjusted Diluted EPS | 6 statements | 7 statements | 1 statement |
| Adjusted EBITDA | 6 statements | 7 statements | 1 statement |
| Capex | — | 3 statements | 1 statement |
| Capital Expenditures | 3 statements | 1 statement | — |
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Jul 28, 2026 | FY2026 Q2 | 0001628280-26-049911 | 10 | Open filing ↗ |
| Apr 30, 2026 | FY2026 Q1 | 0001628280-26-028553 | 10 | Open filing ↗ |
| Feb 10, 2026 | FY2025 Q4 | 0001616862-26-000001 | 12 | Open filing ↗ |
| Oct 28, 2025 | FY2025 Q3 | 0001628280-25-046548 | 11 | Open filing ↗ |
| Jul 30, 2025 | FY2025 Q2 | 0001616862-25-000035 | 12 | Open filing ↗ |
| May 7, 2025 | FY2025 Q1 | 0001616862-25-000020 | 12 | Open filing ↗ |
| Feb 4, 2025 | FY2024 Q4 | 0001616862-25-000009 | 11 | Open filing ↗ |
| Oct 30, 2024 | FY2024 Q3 | 0001616862-24-000063 | 9 | Open filing ↗ |